Leukemia, and its treatment, may pose neurocognitive risks

April 6, 2018

(HealthDay)—Underlying leukemia, even before chemotherapy, may pose a neurocognitive risk to young patients, according to a study published online March 29 in JAMA Oncology.

Yin Ting Cheung, Ph.D., from the St. Jude Children's Research Hospital in Memphis, Tenn., and colleagues examined concentration of cerebrospinal fluid (CSF) biomarkers of brain injury at and during cancer therapy to evaluate associations with long-term neurocognitive outcomes among 235 patients (51.1 percent boys; mean age at diagnosis, 6.8 years; treated from June 1, 2000, through Oct. 31, 2010, and with follow-up being completed on Oct. 21, 2014).

The researchers found that myelin basic and glial fibrillary acidic protein levels were elevated at baseline and through consolidation. There was a positive correlation between the number of intrathecal injections and level increase at consolidation (P = 0.005). There was an association between increases in glial fibrillary acidic protein (risk ratio, 1.23), myelin basic protein (risk ratio, 1.06), and total tau (risk ratio, 1.76) levels and a higher risk for leukoencephalopathy and higher apparent diffusion coefficient in frontal lobe white matter five years after diagnosis (P < 0.001). There was also an association between increase in total tau at consolidation and worse attention (P = 0.04).

"Glial injury may be present at diagnosis of acute lymphoblastic leukemia. Neuronal injury was associated with intrathecal chemotherapy," the authors write. "The CSF biomarkers may be useful in identifying individuals at risk for worse neurologic outcomes, particularly those with genetic susceptibility to poor brain function."

Explore further: Neurocognitive risk may begin before treatment for young leukemia patients

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

Neurocognitive risk may begin before treatment for young leukemia patients

March 29, 2018
Leukemia itself, not just side effects related to its treatment, may increase the risk for long-term problems with attention, organization and related neurocognitive skills in survivors of the most common childhood cancer, ...

New study shows GFAP and UCH-L1 are not useful biomarkers for diagnosing mild traumatic brain injury

February 7, 2017
In patients who suffered acute orthopedic injuries, two proposed biomarkers for mild traumatic brain injury (mTBI) were not able to distinguish between patients who did or did not have mTBI. Relying on elevated levels of ...

Risk of secondary ADHD higher after childhood TBI

March 20, 2018
(HealthDay)—Children with early childhood traumatic brain injury (TBI) have increased risk of secondary attention-deficit/hyperactivity disorder (SADHD), according to a study published online March 19 in JAMA Pediatrics.

Biomarkers in blood shown to be highly selective indicators of brain damage

July 21, 2015
Researchers have shown that the levels of two proteins present in blood and cerebrospinal fluid increase significantly at different time points following traumatic brain injury (TBI), confirming their potential value as biomarkers ...

ASN: Severe acute kidney injury ups risk of 28-day mortality

November 21, 2016
(HealthDay)—Acute kidney injury is associated with increased risk of 28-day mortality among critically ill children and young adults, according to a study published online Nov. 18 in the New England Journal of Medicine. ...

Methotrexate exposure impacts cognitive processes cancer survivors need to multitask

June 6, 2016
Research from St. Jude Children's Research Hospital suggests that pediatric leukemia patients exposed to higher concentrations of the chemotherapy drug methotrexate are more likely to struggle with mental flexibility, organization ...

Recommended for you

First immunotherapy success for triple-negative breast cancer

October 21, 2018
There is new hope for people with an aggressive type of breast cancer, as an immunotherapy trial shows for the first time that lives can be extended in people with triple-negative breast cancer.

Healthy diets linked to better outcomes in colorectal cancer

October 20, 2018
Colorectal cancer patients who followed healthy diets had a lower risk of death from colorectal cancer and all causes, even those who improved their diets after being diagnosed, according to a new American Cancer Society ...

Why some cancers affect only young women

October 19, 2018
Among several forms of pancreatic cancer, one of them specifically affects women, often young. How is this possible, even though the pancreas is an organ with little exposure to sex hormones? This pancreatic cancer, known ...

Scientists to improve cancer treatment effectiveness

October 19, 2018
Together with researchers from the University of Nantes and the University of Reims Champagne-Ardenne in France, experts from the National Research Nuclear University MEPhI have recently developed a quantum dot-based microarray ...

Mutant cells colonize our tissues over our lifetime

October 18, 2018
By the time we reach middle age, more than half of the oesophagus in healthy people has been taken over by cells carrying mutations in cancer genes, scientists have uncovered. By studying normal oesophagus tissue, scientists ...

Study involving hundreds of patient samples may reveal new treatment options of leukemia

October 17, 2018
After more than five years and 672 patient samples, an OHSU research team has published the largest cancer dataset of its kind for a form of leukemia. The study, "Functional Genomic Landscape of Acute Myeloid Leukemia", published ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.